Kenvue Inc. Common Stock vs GraniteShares 2x Long NVDA Daily ETF — how do they compare? Kenvue Inc. Common Stock trades at $17.7 (market cap $34.06B), while GraniteShares 2x Long NVDA Daily ETF trades at $36.86 (market cap $3.56B). The key difference: Kenvue Inc. Common Stock is far larger — about 9.6× GraniteShares 2x Long NVDA Daily ETF's market cap, and Kenvue Inc. Common Stock pays a 4.74% dividend while GraniteShares 2x Long NVDA Daily ETF pays none. Which is the better fit depends on your goals.
| KVUE | NVDL | |
|---|---|---|
Market Cap | $34.06B | $3.56B |
Volume | 23,267,228 | 9,740,643 |
Sector | Consumer Staples | Leveraged / Inverse |
52-Week High | $19.83 | $43.02 |
52-Week Low | $14.11 | $21.76 |
Enterprise Value | $41.56B | — |
Dividend Yield | 4.74% | — |
Typical Hold Time | — | 15 Days |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
NVDL (GraniteShares 2x Long NVDA Daily ETF) trades at $37.28, down 5.79% in the last session. Technical indicators show a bullish bias with moving averages supporting upward momentum while oscillators remain neutral. The ETF provides 2x daily leveraged exposure to NVIDIA, which continues to dominate AI chip markets with strong earnings performance. Recent news highlights ongoing M&A activity in the ETF space and continued AI sector strength.
The outlook remains positive given NVIDIA's market leadership and AI growth trajectory, though leveraged ETF structure introduces volatility risks. Key opportunities include continued AI adoption and NVIDIA's execution, while risks involve leverage decay and sector concentration. Current technical setup suggests potential for recovery toward resistance levels near $39-41 if bullish momentum resumes.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Kenvue is a consumer health company that markets personal care, self-care, and skin health products. Its brands include Tylenol, Listerine, Neutrogena, Johnson’s, BAND-AID Brand, Aveeno, and Zyrtec.
Read more on KVUE →NVDL is a leveraged ETF that seeks daily investment results corresponding to 200% (2x) of the daily performance of NVIDIA Corporation (NVDA) stock. It is designed as a tactical trading tool for investors with a strong bullish (long) view on NVDA. Due to the effects of compounding and leverage, the ETF is intended to be held for a single day and is not suitable for long-term investment, as its performance over longer periods may significantly deviate from two times the performance of the NVDA stock.
Read more on NVDL →